Asia Pacific
-
Chinese medical device company is seeking about $100m -
E-commerce firm eyes top-end pricing, having braved turbulent IPO market conditions
-
Standard Chartered is the sole bookrunner and underwriter of the $400m loan
-
The sovereign is mulling a deal in treacherous market conditions
-
-
The healthcare business of HGS Group has performed solidly since the sponsor-led buyout
-
In this table, GlobalCapital Asia offers a glimpse of the bond deals that are in the works
-
Asian banks are more likely to redeem their AT1s on the first call date than US peers, despite the costs
-
-
Korean firm wraps up fundraising with help from domestic securities house
-
This round-up focuses on the latest GDP numbers as Xi Jinping tightens his grip on China’s ruling party
-
Tencent-backed Chinese healthcare firm remains an IPO hopeful
